课题基金 / 基金详情

AGE Structures and their Biomedical Significance

AGE Structures and their Biomedical Significance
AGE 结构及其生物医学意义
批准号:
10044305
负责人:
HORIUCHI Seikoh
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HORIUCHI Seikoh的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质与葡萄糖长期孵育,通过希夫碱和Amadori产物,形成晚期糖基化终产物(AGE)。从三个方面研究AGE在体内的生物医学意义;(i)体内主要age结构的鉴定,(ii)及其在组织中的定位,(iii) age受体的结构和功能分析。(i)体内主要AGE结构的鉴定:甲基乙二醛通过糖酵解和多元醇途径裂解3-磷酸甘醛生成,与蛋白质反应形成N^ε-(羧乙基)赖氨酸(CEL)等AGE。特别是,甲基乙二醛也是由美拉德反应的席夫碱裂解产生的,随后促进了AGE的进一步形成。(ii) AGE在组织中的定位:在家族性肌萎缩性侧索硬化症患者的肺巨噬细胞中发现了主要的AGE结构之一N^ε-(羧甲基)赖氨酸(CML)的积累,这强烈提示AGE可能参与了这些疾病的发病过程。(iii) AGE受体的结构和功能分析:为了评估AGE受体在肝内皮细胞(LEC)中的表达,我们还确定了在LEC中高表达的B类清道夫受体,如CD-36和SR-BI,是否作为AGE受体。cd -36过表达的CHO细胞表现出对age蛋白的内吞摄取和随后的细胞内降解,表明原位生成的age配体被CD36识别,这可能与糖尿病大血管并发症的发病机制有关。通过使用SR-BI过表达的CHO细胞(SR-BI-CHO),我们清楚地表明SR-BI也作为AGE受体参与AGE蛋白的内吞摄取。此外,age蛋白不仅能有效抑制sr - bi介导的高密度脂蛋白颗粒对CE的选择性摄取,还能抑制SR-BI-CHO细胞中高密度脂蛋白介导的胆固醇外排,这表明age配体在体内HDL介导的胆固醇逆向转运中发挥了重要作用。少
英文摘要
Long-term incubation of proteins with glucose leads, through the Schiff base and Amadori product, to the formation of advanced glycation end products (AGE). The biomedical significance of AGE in vivo were studied from three lines of aspects ; (i) identification of major AGE-structures in vivo, (ii) and their localization in tissues and (iii) structural and functional analyses of AGE-receptors.(i) Identification of major AGE-structures in vivo : Methylglyoxal, which was generated from glycolysis and polyol pathways through the cleavage of gleceraldehyde-3-phosphate, reacted with protein to form the AGE such as N^ε-(carboxyethyl)lysine (CEL). Especially, methylglyoxal was also generated from the cleavage of Schiff base of the Maillard reaction, followed by contribution to further AGE formation.(ii) Localization of AGE in tissues : Accumulation of N^ε-(carboxymethyl)lysine (CML), one of the major AGE structures, has been identified in pulmonary macrophages in patients with pulmonary fibro … More sis and neuron in patient with familial amyotrophic lateral sclerosis, strongly suggesting that AGE may involve in the pathogenesis of these disease processes.(iii) Structural and functional analysis of AGE receptor : To evaluate the AGE-receptor expressed in liver endothelial cells (LEC), we also determined whether scavenger receptor class B such as CD-36 and SR-BI, highly expressed in LEC, serve as an AGE receptor. CD-36-overexpressed CHO cells showed endocytic uptake and subsequent intracellular degradation of AGE-proteins, suggesting that AGE-ligands generated in situ are recognized by CD36, which might contribute to the pathogenesis of diabetic macrovascular complications. By using SR-BI-overexpressed CHO cells (SR-BI-CHO), we clearly showed that SR-BI also serves as an AGE receptor involved in endocytic uptake of AGE-proteins. Furthermore, AGE-protein effectively inhibited not only SR-BI-mediated selective uptake of CE from HDL particles, but also HDL-mediated cholesterol efflux from SR-BI-CHO cells, indicating that AGE-ligands play a significant role in the HDL-mediated reverse cholesterol transport in vivo. Less
期刊论文(141)
专著(0)
科研奖励(0)
会议论文
Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., Makino, H.: "Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy : aminoguanidine ameliorates the overexpression of tumor necrosis factor-alph
Sugimoto, H.、Shikata, K.、Wada, J.、Horiuchi, S.、Makino, H.:“糖尿病肾病发展中的高级糖基化终末产物-细胞因子-一氧化氮序列途径:氨基胍改善肿瘤的过度表达
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Abiko, A., Eto, M., Makino, I., Araki, N., and Horiuchi, S.: "Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay"Metabolism.. 49. 567-573 (2000)
Abiko, A.、Eto, M.、Makino, I.、Araki, N. 和 Horiuchi, S.:“通过免疫化学测定测定自发性糖尿病中国仓鼠的肾脏和肝脏中高级糖基化终产物的水平增加”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 128 条
    Roles of CD36 and SR-BI as novel AGE-receptors
    • 批准号:
      13470228
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2001
    • 负责人:
      HORIUCHI Seikoh
    • 依托单位:
    Role of AGE Receptors in Diabetic Complications
    • 批准号:
      11557081
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.64万
    • 财政年份:
      1999
    • 负责人:
      HORIUCHI Seikoh
    • 依托单位:
    Biological clearance system for advanced glycation end products (AGE) -Insulin signal regulates endocytic uptake of AGE-proteins
    • 批准号:
      09470225
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      1997
    • 负责人:
      HORIUCHI Seikoh
    • 依托单位:
    Molecular Biology of Acyl-coenzyme A : cholesterol Acyltransferase
    • 批准号:
      08044304
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $3.46万
    • 财政年份:
      1996
    • 负责人:
      HORIUCHI Seikoh
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
    • 批准号:
      82505677
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.00万元
    • 批准年份:
      2025
    • 负责人:
      吕雨霏
    • 依托单位:
    麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
    • 批准号:
      82574874
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2025
    • 负责人:
      刘天华
    • 依托单位:
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位: